BTKi
Showing 1 - 25 of 53
BTK Inhibitors-related AF Treated by Catheter Ablation
Not yet recruiting
- BTKi-induced Atrial Fibrillation
- +2 more
- Atrial fibrillation catheter ablation in a population of BTKi-induced atrial fibrillation
-
Caen, Normandy, FranceCaen University Hospital
Nov 10, 2023
Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- BTK inhibitor
- PD-1 inhibitor
-
Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
May 20, 2023
REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy
Not yet recruiting
- CLL, Relapsed
- +3 more
-
Clermont-Ferrand, France
- +7 more
Nov 16, 2022
Relapsed Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Italy (Consolidation with ADCT-402 (loncastuximab
Recruiting
- Relapsed Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Consolidation with ADCT-402 (loncastuximab tesirine) after salvage immunochemotherapy (R-BAC, Rituximab - Bendamustine, Ara-C))
-
Brescia, Italy
- +19 more
Apr 22, 2022
Relapsed/Refractory Trial in Santa Fe (Tafasitamab, Lenalidomide, Tazemetostat)
Recruiting
- Relapsed/Refractory
- Tafasitamab
- +8 more
-
Santa Fe, CaliforniaCalifornia Cancer Associates For Research And Excellence, cCARE
Feb 23, 2022
Lymphocytic Leukemia, Chronic, Lymphoma, Small Lymphocytic Trial in Canada, United States (IPI-145 (duvelisib), Obinutuzumab)
Terminated
- Lymphocytic Leukemia, Chronic
- Lymphoma, Small Lymphocytic
- IPI-145 (duvelisib)
- Obinutuzumab
-
La Jolla, California
- +6 more
Mar 15, 2021
B-cell Malignancies Undergoing Treatment With Bruton Tyrosine
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +4 more
- Non-Interventional Study
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 22, 2023
PICAROS - Acalabrutinib RWE on 1L CLL in Spain
Recruiting
- Chronic Lymphocytic Leukemia
-
Almeria, Andalucia, Spain
- +36 more
Aug 10, 2023
Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 16, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- +2 more
- Tafasitamab
- +2 more
-
Jacksonville, Florida
- +16 more
Dec 10, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Duvelisib)
Withdrawn
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Tempe, Arizona
- +7 more
Mar 15, 2021
CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)
Not yet recruiting
- CLL/SLL
- lisaftoclax +BTK inhibitor
- BTK inhibitor
- (no location specified)
Oct 26, 2023
B-cell Non Hodgkin Lymphoma Trial in Xuzhou (regimen with BTK inhibitor +Anti-CD19 CAR T cells)
Recruiting
- B-cell Non Hodgkin Lymphoma
- regimen with BTK inhibitor +Anti-CD19 CAR T cells
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023
Chronic Lymphocytic Leukemia, CLL Progression, CLL/SLL Trial in New York (Umbralisib, Ublituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
-
New York, New YorkWeill Cornell Medicine
Mar 29, 2022
Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)
Recruiting
- Waldenstrom Macroglobulinemia
- Zanubrutinib, Bendamustine and Rituximab
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jun 13, 2023
Lymphoma Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (PNEUMOVAX 23, Fluarix, FluLaval)
Recruiting
- Lymphoma
- PNEUMOVAX 23
- +9 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +7 more
-
Manchester, United Kingdom
- +2 more
Aug 11, 2022
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Chandler, Arizona
- +107 more
Mar 8, 2022
r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase
Not yet recruiting
- B-cell Lymphoma
-
Beijing, Beijing, ChinaDeparment of Hematology, Peking University People's Hospital
Aug 9, 2022
Mantle Cell Lymphoma, MCL Trial in United States (Tafasitamab, Lenalidomide)
Recruiting
- Mantle Cell Lymphoma
- MCL
-
Basking Ridge, New Jersey
- +6 more
Mar 27, 2023
Relapsed/Refractory Mantle Cell Lymphoma Trial in Worldwide (Fludarabine, Cyclophosphamide, Brexucabtagene autoleucel)
Recruiting
- Relapsed/Refractory Mantle Cell Lymphoma
- Fludarabine
- +2 more
-
Gilbert, Arizona
- +40 more
Jan 6, 2023
LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational
Not yet recruiting
- Relapsed Non-Hodgkin Lymphoma
- (no location specified)
Sep 19, 2023
Biological Insights of First Relapsed-refractory Mantle Cell
Not yet recruiting
- Mantle Cell Lymphoma
-
Milano, MI, Italy
- +29 more
Nov 11, 2021
Waldenstrom's Disease, Prognostic Index Trial in France
Not yet recruiting
- Waldenstrom's Disease
- Prognostic Index
-
Amiens, France
- +14 more
Jun 12, 2023